Reply to thread

down a percent or 2 today ... $6.70

Highlights

▪ Total Unaudited Revenue1 of $19m, +64% growth Year-on-Year (1H FY23: $11.5m)

▪ EBITDA of $2.3m; +262% growth on 1H FY23 ($0.63m) highlighting improved margin conversion

▪ Global partnership with Barrick Gold and MSALABS to deploy up to 13 PhotonAssayTM units, showcasing continuing adoption by one of the world’s largest gold miners

▪ Strong cash position of $85m as of 31 December 2023, including proceeds from $75m Institutional Placement, and supported by an increased Commonwealth Bank of Australia debt facility providing a total of $180m available for growth

▪ FY24 financial guidance unchanged from Q2 FY24 Announcement and 4C

Chrysos Managing Director and CEO Dirk Treasure, commented:

"Chrysos achieved +64% year-on-year growth in revenue during the reporting period, with a strong +262% growth in EBITDA. Our EBITDA margin improved, driven by our strategy to scale efficiently in key mining hubs. The company is well positioned for further growth supported by a strong cash balance, and boosted by our successful $75m Institutional Placement and increased funding facility from the CBA.”

“A key achievement during the half-year was our new global partnership with Barrick Gold and MSALABS to deploy up to 13 PhotonAssay units to Barrick mine sites across four continents by the end of 2025. This partnership is a watershed moment for the business and is validation, by one of the world’s largest miners, of PhotonAssay’s superiority in the gold analysis space.”